M. Cattaneo et al., Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion, THROMB RES, 96(3), 1999, pp. 213-217
The template bleeding time is still the screening test for defects of plate
let function, although it is an invasive and poorly reproducible technique.
The PFA-100 measures platelet function at high shear. Whole blood is aspir
ated through a capillary to an aperture of a membrane coated with platelet
agonists. The system measures the time required to obtain occlusion of the
aperture by a platelet plug (closure time). We measured the closure times i
n the PFA-100 system and the bleeding time in seven patients with delta-sto
rage pool deficiency, 10 patients with "primary secretion defect" (not due
to abnormalities of platelet granules or the arachidonate pathway), and 40
controls. Measurements were repeated 1 and 4 hours after intravenous infusi
on of desmopressin in six delta-storage pool deficiency and eight primary s
ecretion defect patients. Baseline bleeding time and closure times with the
collagen/epinephrine cartridge were longer in delta-storage pool deficienc
y and primary secretion defect patients than in controls. In contrast, clos
ure times with the collagen/adenosine diphosphate cartridge were normal in
both delta-storage pool deficiency and primary secretion defect patients. T
reatment with desmopressin increased the plasma von Willebrand Factor level
s, shortened the prolonged bleeding time, shortened the closure times with
the collagen/adenosine diphosphate cartridge, and normalized the closure ti
mes with the collagen/epinephrine cartridge, Therefore, the PFA-100 test ma
y be a less invasive alternative to the bleeding time in the diagnosis and
therapeutic monitoring of patients with platelet secretion defects. The col
lagen/epinephrine cartridge is more sensitive than the collagen/adenosine d
iphosphate cartridge to defects of platelet secretion. (C) 1999 Elsevier Sc
ience Ltd. All rights reserved.